Cyclic peptide-based potent human SIRT6 inhibitors?

Organic & Biomolecular Chemistry Pub Date: 2016-05-25 DOI: 10.1039/C5OB02339D

Abstract

We discovered in the current study that six side chain-to-side chain cyclic pentapeptides harboring a central Nε-dodecyl (or tetradecyl)-thiocarbamoyl-lysine residue all behaved as highly potent (nM level) inhibitors against human SIRT6-catalyzed deacylation reaction. Moreover, one compound was also found to be selective for SIRT6 versus SIRT2/3/5 (~20-, ~11-, and >940-fold, respectively), despite its modest (~2.3-fold) SIRT6 inhibitory selectivity versus SIRT1. These compounds could be valuable leads for the identification of further potent and selective human SIRT6 inhibitors.

Graphical abstract: Cyclic peptide-based potent human SIRT6 inhibitors
Recommended Literature